NON SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may keep stage III lung cancer at bay after Chemo-Radiation
Disease control Not yet recruitingThis study tests a drug called ivonescimab given for one year after standard chemoradiation in people with stage III lung cancer that cannot be removed by surgery. The goal is to see if it can delay the cancer from growing or spreading. About 63 participants will receive the drug…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
New drug combo aims to shrink inoperable lung tumors enough for surgery
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and toripalimab, in 50 adults with stage III non-small cell lung cancer that cannot be surgically removed. The goal is to see if the treatment can shrink tumors enough to allow surgery and improve survival. Part…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 17, 2026 02:02 UTC